Patients with stage 3 and 4 macular holes of size \>700 microns who underwent pars plana vitrectomy, Internal limiting Membrane peeling and silicone oil tamponade were followed at day 1 , 2 weeks and 1 month post silicone oil removal and anatomical closure of macular hole assessed at all intervals
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Percentage of eyes with Immediate Anatomical Closure of Macular hole
Timeframe: Day 1
Percentage of eyes having Type I Closure of Macular hole
Timeframe: Day 1; 2 weeks after surgery ; 1 month post silicone oil removal
Percentage of eyes having Type II Closure of Macular hole
Timeframe: At Day 1, 2 weeks after surgery and 1 month post Silicone oil removal
Percentage of eyes having Open Macular hole
Timeframe: At Day 1, 2 weeks after surgery and 1 month post Silicone oil removal
Adverse events
Timeframe: Day 1